Cargando…

Adverse Events Related to SARS-CoV-2 Vaccine in a Nationwide Cohort of Patients With Inflammatory Bowel Disease

There are limited data on the safety profile of the severe acute respiratory syndrome coronavirus-2 vaccine among patients taking immunosuppressive medications. Our aim was to evaluate the adverse events related to the vaccines in a nationwide cohort of patients with inflammatory bowel disease on di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahmud, Nadim, Reinisch, Walter, Patel, Manthankumar, Sundararajan, Ramaswamy, Khan, Nabeel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132715/ https://www.ncbi.nlm.nih.gov/pubmed/36508224 http://dx.doi.org/10.14309/ctg.0000000000000554

Ejemplares similares

Incidence of Long COVID and Impact of Medications on the Risk of Developing Long COVID in a Nationwide Cohort of IBD Patients
por: Khan, Nabeel, et al.
Publicado: (2023)

Impact of Biologics on SARS-COV-2 Disease Course When Infused Within 2 Weeks of Acquiring the Infection Among IBD Patients
por: Khan, Nabeel, et al.
Publicado: (2023)

Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications
por: Khan, Nabeel, et al.
Publicado: (2021)

Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System
por: Khan, Nabeel, et al.
Publicado: (2021)

Adverse Events and Serological Responses After SARS-CoV-2 Vaccination in Individuals With Inflammatory Bowel Disease
por: Markovinović, Ante, et al.
Publicado: (2023)

COVID-19 Vaccine Effectiveness Against the Omicron Variant in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease
por: Khan, Nabeel, et al.
Publicado: (2023)

Adherence of Infusible Biologics During the Time of COVID-19 Among Patients With Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study
por: Khan, Nabeel, et al.
Publicado: (2020)

Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study
por: Khan, Nabeel, et al.
Publicado: (2020)

Risk of Venous Thromboembolism Among Patients With Inflammatory Bowel Disease Who Contract Severe Acute Respiratory Syndrome Coronavirus 2
por: Mahmud, Nadim, et al.
Publicado: (2021)

SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
por: Gubatan, John, et al.
Publicado: (2020)

Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
por: Khan, Nabeel, et al.
Publicado: (2017)

Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease
por: Orfanoudaki, Eleni, et al.
Publicado: (2022)

A170 ADVERSE EVENTS & SEROLOGICAL RESPONSES FOLLOWING SARS-COV-2 VACCINATION IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
por: Markovinovic, A, et al.
Publicado: (2023)

Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases
por: Pokryszka, Jagoda, et al.
Publicado: (2022)

Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Orfanoudaki, Eleni, et al.
Publicado: (2022)

Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2022)

Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain)
por: Rodríguez-Lago, Iago, et al.
Publicado: (2020)

Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies
por: Boland, Brigid S., et al.
Publicado: (2022)

Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
por: Tsipotis, Evangelos, et al.
Publicado: (2023)

Post‐Covid‐19‐vaccination adverse events and healthcare utilization among individuals with or without previous SARS‐CoV‐2 infection
por: Lai, Francisco Tsz Tsun, et al.
Publicado: (2022)

Patient characterization and adverse health care-related events in SARS-CoV-2 infected patients who died in a tertiary hospital()
por: Mena, Guillermo, et al.
Publicado: (2021)

Reduction in Inflammatory Bowel Disease Healthcare During the Coronavirus Disease 2019 Pandemic: A Nationwide Retrospective Cohort Study
por: te Groen, Maarten, et al.
Publicado: (2021)

Inflammatory Bowel Disease
por: Lee, Shona J., et al.
Publicado: (2014)

Intracranial inflammatory mediators involved in SARS-CoV-2 neurological manifestations?
por: Flemming, Alexandra
Publicado: (2021)

Time of Bariatric Surgery and Hospitalization for SARS-CoV-2: a Nationwide Study
por: Poghosyan, Tigran, et al.
Publicado: (2021)

The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy
por: Li, Dalin, et al.
Publicado: (2022)

Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes: A nationwide study
por: Mårild, Karl, et al.
Publicado: (2022)

Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor ACE2 and TMPRSS2 in Inflammatory Bowel Disease
por: Nowak, Jan Krzysztof, et al.
Publicado: (2020)

Influence of nonalcoholic fatty liver disease on inflammatory bowel disease hospitalizations in the United States
por: Soni, Aakriti, et al.
Publicado: (2023)

Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland’
por: Muñoz, Manuel, et al.
Publicado: (2021)

Adverse Events Associated with Azathioprine Treatment in Korean Pediatric Inflammatory Bowel Disease Patients
por: Chun, Ji Young, et al.
Publicado: (2013)

Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2019)

SARS-CoV-2 Viral Load and Myocardial Injury: Independent and Incremental Predictors of Adverse Outcome
por: Chehab, Omar, et al.
Publicado: (2021)

Evaluating imbalances of adverse events during biosimilar development
por: Vana, Alicia M., et al.
Publicado: (2016)

Pivot to Asia: inflammatory bowel disease burden
por: Singh, Prashant, et al.
Publicado: (2017)

Effect of inflammatory bowel diseases on household chores
por: Mattila, Kalle, et al.
Publicado: (2023)

ceRNA analysis of SARS-CoV-2
por: Arancio, Walter
Publicado: (2020)

Trends in SARS-CoV-2 seroprevalence amongst urban paediatric patients compared with a nationwide cohort in the Netherlands
por: Rotee, I.L.M., et al.
Publicado: (2021)

The Impact of SARS-CoV-2 on Inflammatory Bowel Disease
por: Estevinho, Maria Manuela, et al.
Publicado: (2020)

Drug-Related Adverse Events Necessitating Treatment Discontinuation in Pediatric Inflammatory Bowel Disease Patients
por: Salzmann, Medea, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i6quuc4t8ii2dr6512nlfbksr9